Clinical trial
Sildenafil for Treatment of Choroidal Ischemia
NCT04356716 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sildenafil for Treatment of Choroidal Ischemia
- Lead sponsor
- Columbia University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 11, 2014
- Completion date
- February 18, 2020
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
age-related macular degeneration, central serous retinopathy, choroidal ischemia, retinitis pigmentosa, vitelliform macular dystrophy